国际眼科纵览 ›› 2013, Vol. 37 ›› Issue (3): 186-190.doi: 10 3760/ cma. j. issn.16735803 2013 03 010

• 综述 • 上一篇    下一篇

中心性浆液性脉络膜视网膜病变的治疗

刘艳  邓爱军  吕小辉   

  1. 261031 山东,潍坊医学院附属医院眼科
  • 收稿日期:2013-04-14 出版日期:2013-06-22 发布日期:2013-06-27
  • 通讯作者: 邓爱军,Email: dengaijun@hotmail.com E-mail:dengaijun@hotmail.com

The  treatment of central serous chorioretinopathy

LIU Yan, DENG Ai-jun, LV Xiao-hui   

  1. Department of Ophthalmology, Hospital Affliated with Weifang Medical College, Shandong 261031, China
  • Received:2013-04-14 Online:2013-06-22 Published:2013-06-27
  • Contact: DENG Aijun, Email: dengaijun@hotmail.com E-mail:dengaijun@hotmail.com

摘要: 中心性浆液性脉络膜视网膜病变好发于中青年男性,大多数病例视网膜下积液可自行吸收,视力预后良好,但也有部分患者迁延不愈,生活质量明显下降。目前临床尚无针对性治疗方法,近几年来随着人们对此病的重视和影像学的快速发展,其早期诊断率不断提高, 药物、激光及各种新兴治疗方法的应用也使治愈率不断提高。本文就目前对该病的各种治疗方法进行综述,探讨中心性浆液性视网膜脉络膜病变的可行性治疗方案及其利与弊。

Abstract: Central serous chorioretinopathy(CSC) is a common eye disease in young and middleaged men. Although the under retina effusion would be absorbed spontaneously in most of the cases and the visual acuity would be good, the life qualities in some patients still decreased obviously because of the protracted course of CSC. At present, there is no targeted treatment for this disease. With the rapid development of fundus imaging in recent years, the early diagnostic rate improved continuously. Drugs, laser and various emerging therapies make the cure rate increase. In this paper, we analysis the current treatments for CSC and compare the advantages and disadvantages of each treatment in order to find the most effective way in clinic.